Home » The Netherlands’ Crucell Signs Deal With Merck & Co
The Netherlands’ Crucell Signs Deal With Merck & Co
Crucell has been boosted by the news that drugs giant Merck & Co has exercised an option for the exclusive use of the Dutch firm’s PER.C6 technology.
Pharma Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May